| 000 | 01547 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516232854.0 | ||
| 264 | 0 | _c20161101 | |
| 008 | 201611s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/jdv.12720 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeverino-Freire, M | |
| 245 | 0 | 0 |
_aAcquired perforating dermatosis associated with sorafenib therapy. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cFeb 2016 |
||
| 300 |
_a328-30 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aReceptors, Vascular Endothelial Growth Factor |
| 650 | 0 | 4 |
_aSkin _xpathology |
| 650 | 0 | 4 |
_aSkin Diseases _xdrug therapy |
| 650 | 0 | 4 | _aSorafenib |
| 700 | 1 | _aSibaud, V | |
| 700 | 1 | _aTournier, E | |
| 700 | 1 | _aPauwels, C | |
| 700 | 1 | _aChristol, C | |
| 700 | 1 | _aLamant, L | |
| 700 | 1 | _aHautier-Mazeereuw, J | |
| 700 | 1 | _aPeron, J-M | |
| 700 | 1 | _aPaul, C | |
| 700 | 1 | _aBulai Livideanu, C | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 30 _gno. 2 _gp. 328-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jdv.12720 _zAvailable from publisher's website |
| 999 |
_c24179358 _d24179358 |
||